Articles

  1. Online Community Programs - Changing The Game 4/4/2012
    Why are online community programs being used to connect physicians and other healthcare professionals (HCP)?
  2. Kemwell Biopharma Brochure 3/29/2012
    Kemwell Biopharma will offer services ranging from full-service process development, manufacture, formulation and fill and finish at the cGMP manufacturing facility in Bangalore, India as a one-stop-shop through access to Boehringer Ingelheim's® cell line development with the BI HEX technology platform, followed by a preferred access to the large-scale commercial production of Boehringer Ingelheim at its facilities in Europe.
  3. DSM's Route Scouting & Implementation of Synthetic Processes Is A Cost-effective Solution For Commercialization 3/28/2012
    DSM's cost-effective solution in route design and implementation of synthetic processes offers the capability to support emerging pharma companies with high potential and biotechs project and small molecule projects.
  4. DSM's CMO Expertise In Traditional Chemistries & Innovative Green Chemistry 3/28/2012
    DSM contract manufacturing services offer the technology and expertise to deliver sustainability and value via a broad range of traditional chemistries and innovative green chemistry.
  5. Sterile Clinical Trial Material Formulation & Filling 3/26/2012
    DSM offers sterile clinical trial formulation and filling that meets the unique needs of global pharmaceutical and biotech customers.
  6. Cytotoxic Formulation & Filling 3/26/2012
    DSM expanded their commercial-scale sterile pharmaceutical services by offering filling and lyophilization of cytotoxic products.
  7. Accelerated Drug Development: The Promise Is In The Process 3/21/2012

    In 1993, the FDA issued the call to the pharmaceutical industry to streamline the drug development process from discovery to First In Man. By Jan-Olav Henck, Ph.D., Chief Scientific Officer, Aptuit LLC

  8. Due Diligence & Document Management 3/2/2012

    Funding, licensing, and partnerships are the lifeblood for the Life Science industry. New sources of funding are critical to the continuing development of your programs and will determine your exit strategy.

  9. Brochure: RHOBUST® Downstream Processing Technology 2/22/2012
    Rhobust® technology is a downstream processing technology for the manufacturing of recombinant proteins and antibodies.
  10. Brochure: XD® Technology: Improve Biopharmaceutical Production 2/22/2012
    DSM's XD® Technology has been developed to drive yield improvements in the production of biopharmaceuticals.